Pixium Vision convenes a Combined General Meeting of Shareholders on April 19, 2022
March 14, 2022 14:00 ET | Pixium Vision
Pixium Vision convenes a Combined General Meeting of Shareholders on April 19, 2022 Paris, France, March 14, 2022 – 19:00 CET– Pixium Vision SA (Euronext Growth Paris - FR0011950641; Mnemo:...
Pixium Vision convoque une assemblée générale mixte des actionnaires le 19 avril 2022
March 14, 2022 14:00 ET | Pixium Vision
Pixium Vision convoque une assemblée générale mixte des actionnaires le 19 avril 2022 Paris, France, 14 mars 2022 – 19 h CET– Pixium Vision SA (Euronext Growth Paris - FR0011950641; Mnemo: ALPIX),...
Pixium Vision announces its unaudited financial results for 2021 and provides a business update
February 22, 2022 01:00 ET | Pixium Vision
        Pixium Vision announces its unaudited financial results for 2021 and provides a business update Cash position on 31 December 2021: €14.5 millionCash runway to end of Q4 2022Clinical...
Pixium Vision annonce ses résultats annuels 2021 non audités et fait le point sur ses activités
February 22, 2022 01:00 ET | Pixium Vision
7 Pixium Vision annonce ses résultats annuels 2021 non audités et fait le point sur ses activités Trésorerie au 31 décembre 2021: 14,5 millions d’eurosSécurisation de la trésorerie jusqu’au...
Pixium Vision announces the publication in Nature Communications of peer-reviewed clinical data demonstrating the clinical benefit of the Prima System in Dry AMD patients
January 27, 2022 01:00 ET | Pixium Vision
Pixium Vision announces the publication in Nature Communications of peer-reviewed clinical data demonstrating the clinical benefit of the Prima System in Dry AMD patients Paris, France, January 27,...
Pixium Vision annonce la publication dans Nature Communications de données cliniques évaluées par des pairs, démontrant le bénéfice clinique du Système Prima chez les patients atteints de DMLA sèche
January 27, 2022 01:00 ET | Pixium Vision
Pixium Vision annonce la publication dans Nature Communications de données cliniques évaluées par des pairs, démontrant le bénéfice clinique du Système Prima chez les patients atteints de DMLA sèche ...
Pixium Vision to attend BIOMED EVENT® by Invest Securities on January 26, 2022
January 06, 2022 01:00 ET | Pixium Vision
Pixium Vision to attend BIOMED EVENT® byInvest Securities on January 26, 2022 Paris, France, January 6, 2022 – 07:00 CET– Pixium Vision SA (Euronext Growth Paris - FR0011950641), a bioelectronics...
Pixium Vision participera au BIOMED EVENT® organisé par Invest Securities le 26 janvier 2022
January 06, 2022 01:00 ET | Pixium Vision
Pixium Vision participera au BIOMED EVENT® organisé par Invest Securities le 26 janvier 2022 Paris, France, 6 janvier 2022 – 7 h CET– Pixium Vision SA (Euronext Growth Paris : FR0011950641),société...
Pixium-color-2600x800.png
Pixium Vision to attend 11th Annual LifeSci Partners Corporate Access Event
December 14, 2021 01:00 ET | Pixium Vision
Pixium Vision to attend 11th Annual LifeSci Partners Corporate Access Event CEO Lloyd Diamond to participate in a panel discussion on “Med Tech / Digital Tools: What’s the Mindset for 2022?” –...
Pixium Vision gaining confidence in execution timeline of the PRIMAvera pivotal trial following first patient implantation in the UK
December 08, 2021 01:00 ET | Pixium Vision
Pixium Vision gaining confidence in execution timeline of the PRIMAvera pivotal trial following first patient implantation in the UK Successful implantation of the first patient in the PRIMAvera...